Annual ROA
-47.81%
+2.02%+4.05%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual return on assets is -47.81%, with the most recent change of +2.02% (+4.05%) on December 31, 2023.
- During the last 3 years, KPTI annual ROA has risen by +16.75% (+25.94%).
- KPTI annual ROA is now -19.44% below its all-time high of -40.03%, reached on December 31, 2014.
Performance
KPTI ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-39.11%
-2.46%-6.71%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly return on assets is -39.11%, with the most recent change of -2.46% (-6.71%) on September 30, 2024.
- Over the past year, KPTI quarterly ROA has dropped by -2.46% (-6.71%).
- KPTI quarterly ROA is now -19.13% below its all-time high of -32.83%, reached on September 30, 2022.
Performance
KPTI Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
KPTI ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.0% | -6.7% |
| 3 y3 years | +25.9% | +44.4% |
| 5 y5 years | +30.1% | +48.2% |
KPTI ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.1% | +4.0% | -19.1% | +31.6% |
| 5 y | 5-year | -19.1% | +25.9% | -19.1% | +44.4% |
| alltime | all time | -19.4% | +87.2% | -19.1% | +96.2% |
Karyopharm Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -39.11%(+6.7%) |
| Jun 2024 | - | -36.65%(-32.9%) |
| Mar 2024 | - | -54.66%(+14.0%) |
| Dec 2023 | -47.81%(-4.1%) | -47.95%(+1.8%) |
| Sep 2023 | - | -47.12%(-2.2%) |
| Jun 2023 | - | -48.17%(-10.6%) |
| Mar 2023 | - | -53.90%(-5.8%) |
| Dec 2022 | -49.83%(+24.2%) | -57.19%(+74.2%) |
| Sep 2022 | - | -32.83%(-11.5%) |
| Jun 2022 | - | -37.08%(-2.9%) |
| Mar 2022 | - | -38.19%(-11.7%) |
| Dec 2021 | -40.13%(-37.8%) | -43.27%(-38.5%) |
| Sep 2021 | - | -70.33%(+7.7%) |
| Jun 2021 | - | -65.29%(+12.0%) |
| Mar 2021 | - | -58.30%(+3.5%) |
| Dec 2020 | -64.56%(+2.9%) | -56.34%(-3.5%) |
| Sep 2020 | - | -58.36%(+0.3%) |
| Jun 2020 | - | -58.20%(-4.2%) |
| Mar 2020 | - | -60.74%(-11.2%) |
| Dec 2019 | -62.75%(-8.3%) | -68.39%(-9.5%) |
| Sep 2019 | - | -75.55%(-6.0%) |
| Jun 2019 | - | -80.36%(-2.4%) |
| Mar 2019 | - | -82.35%(+5.6%) |
| Dec 2018 | -68.42% | -77.95%(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -82.33%(+8.3%) |
| Jun 2018 | - | -76.01%(-8.1%) |
| Mar 2018 | - | -82.69%(+11.0%) |
| Dec 2017 | -71.52%(+29.2%) | -74.50%(+10.8%) |
| Sep 2017 | - | -67.25%(+5.5%) |
| Jun 2017 | - | -63.73%(+0.0%) |
| Mar 2017 | - | -63.70%(+9.6%) |
| Dec 2016 | -55.37%(+2.1%) | -58.13%(+4.0%) |
| Sep 2016 | - | -55.90%(+3.4%) |
| Jun 2016 | - | -54.06%(+8.9%) |
| Mar 2016 | - | -49.66%(+3.2%) |
| Dec 2015 | -54.24%(+35.5%) | -48.12%(+4.4%) |
| Sep 2015 | - | -46.11%(+1.4%) |
| Jun 2015 | - | -45.46%(+6.7%) |
| Mar 2015 | - | -42.61%(+1.3%) |
| Dec 2014 | -40.03%(-5.9%) | -42.07%(-0.1%) |
| Sep 2014 | - | -42.10%(-8.0%) |
| Jun 2014 | - | -45.77%(+16.0%) |
| Mar 2014 | - | -39.47%(-19.2%) |
| Dec 2013 | -42.56%(-88.6%) | -48.86%(-25.1%) |
| Sep 2013 | - | -65.27%(+2.3%) |
| Jun 2013 | - | -63.81%(-93.8%) |
| Mar 2013 | - | -1028.53%(+71.3%) |
| Dec 2012 | -372.30%(+160.8%) | -600.53% |
| Dec 2011 | -142.73% | - |
FAQ
- What is Karyopharm Therapeutics annual return on assets?
- What is the all time high annual ROA for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual ROA year-on-year change?
- What is Karyopharm Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly ROA year-on-year change?
What is Karyopharm Therapeutics annual return on assets?
The current annual ROA of KPTI is -47.81%
What is the all time high annual ROA for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual return on assets is -40.03%
What is Karyopharm Therapeutics annual ROA year-on-year change?
Over the past year, KPTI annual return on assets has changed by +2.02% (+4.05%)
What is Karyopharm Therapeutics quarterly return on assets?
The current quarterly ROA of KPTI is -39.11%
What is the all time high quarterly ROA for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly return on assets is -32.83%
What is Karyopharm Therapeutics quarterly ROA year-on-year change?
Over the past year, KPTI quarterly return on assets has changed by -2.46% (-6.71%)